These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 27100417

  • 1. Characteristics, Treatment, and Long-Term Outcome of Gastrointestinal Involvement in Behcet's Syndrome: A Strobe-Compliant Observational Study From a Dedicated Multidisciplinary Center.
    Hatemi I, Esatoglu SN, Hatemi G, Erzin Y, Yazici H, Celik AF.
    Medicine (Baltimore); 2016 Apr; 95(16):e3348. PubMed ID: 27100417
    [Abstract] [Full Text] [Related]

  • 2. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I, Hatemi G, Pamuk ON, Erzin Y, Celik AF.
    Clin Exp Rheumatol; 2015 Apr; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.
    Zou J, Shen Y, Ji DN, Zheng SB, Guan JL.
    World J Gastroenterol; 2014 Dec 07; 20(45):17171-8. PubMed ID: 25493032
    [Abstract] [Full Text] [Related]

  • 4. Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.
    Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.
    Rheumatology (Oxford); 2018 Dec 01; 57(12):2200-2212. PubMed ID: 30107448
    [Abstract] [Full Text] [Related]

  • 5. Long term follow-up of Behçet's syndrome patients treated with cyclophosphamide.
    Gurcan M, Esatoglu SN, Hamuryudan V, Saygin D, Ugurlu S, Seyahi E, Melikoglu M, Fresko I, Yurdakul S, Yazici H, Hatemi G.
    Rheumatology (Oxford); 2020 Sep 01; 59(9):2264-2271. PubMed ID: 31840168
    [Abstract] [Full Text] [Related]

  • 6. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
    Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C, Yurdakul S, Yazici H.
    Rheumatology (Oxford); 2010 Jan 01; 49(1):173-7. PubMed ID: 19995858
    [Abstract] [Full Text] [Related]

  • 7. Predictors of infliximab refractory intestinal Behçet's syndrome: A retrospective cohort study from the Shanghai Behçet's syndrome database.
    Bao HF, Hou CC, Ye B, Zou J, Luo D, Cai JF, Shen Y, Guan JL.
    Mod Rheumatol; 2023 Jan 03; 33(1):207-216. PubMed ID: 34932796
    [Abstract] [Full Text] [Related]

  • 8. Surgical Treatment of Pulmonary Complications in Behçet's Syndrome.
    Tuzun H, Seyahi E, Guzelant G, Oz B, Batur S, Demirhan O, Hamuryudan V.
    Semin Thorac Cardiovasc Surg; 2023 Jan 03; 30(3):369-378. PubMed ID: 30031945
    [Abstract] [Full Text] [Related]

  • 9. Clinical features and prognosis of patients with gastrointestinal Behçet's disease-like syndrome and myelodysplastic syndrome with and without trisomy 8.
    Liu Z, Yang C, Bai X, Shen K, Qiao L, Wang Q, Yang H, Qian J.
    Semin Arthritis Rheum; 2022 Aug 03; 55():152039. PubMed ID: 35689913
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal manifestations of Behçet's disease in Japan: a study of 43 patients.
    Ideguchi H, Suda A, Takeno M, Miyagi R, Ueda A, Ohno S, Ishigatsubo Y.
    Rheumatol Int; 2014 Jun 03; 34(6):851-6. PubMed ID: 23934478
    [Abstract] [Full Text] [Related]

  • 11. Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK, Kim JH, Song JK, Yoo B, Yu CS.
    Dis Colon Rectum; 2007 May 03; 50(5):672-6. PubMed ID: 17216141
    [Abstract] [Full Text] [Related]

  • 12. Infliximab for vascular involvement in Behçet's syndrome.
    Hatemi G, Tukek NB, Esatoglu SN, Ozguler Y, Taflan SS, Uygunoglu U, Melikoglu M, Ugurlu S, Fresko I, Siva A, Kutlubay Z, Yurdakul S, Yazici H, Hamuryudan V.
    Clin Immunol; 2023 Aug 03; 253():109682. PubMed ID: 37385325
    [Abstract] [Full Text] [Related]

  • 13. Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network.
    Sota J, Rigante D, Lopalco G, Emmi G, Gentileschi S, Gaggiano C, Ciarcia L, Berlengiero V, Mourabi M, Ricco N, Barneschi S, Mattioli I, Tosi GM, Frediani B, Tarsia M, di Scala G, Vitale A, Iannone F, Fabiani C, Cantarini L.
    Intern Emerg Med; 2021 Nov 03; 16(8):2163-2171. PubMed ID: 33835406
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of de novo major involvement during follow-up in Behçet's syndrome.
    Talarico R, Cantarini L, d'Ascanio A, Figus M, Favati B, Baldini C, Tani C, Neri R, Bombardieri S, Mosca M.
    Clin Rheumatol; 2016 Jan 03; 35(1):247-50. PubMed ID: 25750177
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course.
    Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H.
    Rheumatology (Oxford); 2014 Nov 03; 53(11):2018-22. PubMed ID: 24907156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.